Revisiting MHC genes in spondyloarthritis

Current Rheumatology Reports

Volumn 17, Issue 6, 2015, Pages

  Breban, Maxime ^a,b,c   Costantino, Félicie ^a,b,c   André, Claudine ^a,b,c   Chiocchia, Gilles ^a,b,c   Garchon, Henri Jean ^a,b,c,d  

^a HÔPITAL AMBROISE PARÉ   (France)

^b LABORATOIRE DES SCIENCES DU CLIMAT ET DE L ENVIRONNEMENT   (France)

^c Genetics Division Ambroise Paré Hospital AP HP ^*  (France)

^d UNIVERSITÉ PARIS DESCARTES   (France)

Author keywords

Ankylosing spondylitis; Antigen presenting cell; Dendritic cell; ERAP; HLA, HLA B27; HLA DP; HLA DR; HLA E; MHC; MICA; Natural killer cell; Peptide; Peptidome; Psoriatic arthritis; Spondyloarthritis; Transgenic rat

Indexed keywords

AMINOPEPTIDASE; HLA A ANTIGEN; HLA B ANTIGEN; HLA B27 ANTIGEN; HLA C ANTIGEN; HLA DM ANTIGEN; HLA DO ANTIGEN; HLA DP ANTIGEN; HLA DQ ANTIGEN; HLA DR ANTIGEN; KILLER CELL IMMUNOGLOBULIN LIKE RECEPTOR; LYMPHOTOXIN; LYMPHOTOXIN BETA; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; TUMOR NECROSIS FACTOR ALPHA;

ANTIGEN PRESENTATION; ARTICLE; ERAP1 GENE; ERAP2 GENE; FAMILIAL DISEASE; GENE; GENE FREQUENCY; GENE FUNCTION; GENE IDENTIFICATION; GENE LINKAGE DISEQUILIBRIUM; GENE LOCATION; GENE LOCUS; GENETIC ASSOCIATION; GENETIC EPIDEMIOLOGY; GENETIC PREDISPOSITION; GENETIC RISK; HERITABILITY; HLA A GENE; HLA B GENE; HLA B27 GENE; HLA C GENE; HLA DM GENE; HLA DO GENE; HLA DP GENE; HLA DQ GENE; HLA DR GENE; HUMAN; KIR GENE; LNPEP GENE; MAJOR HISTOCOMPATIBILITY COMPLEX; MHC GENE; MOLECULAR PATHOLOGY; NONHUMAN; NPEPPS GENE; SPONDYLARTHRITIS; TNF ALPHA GENE; TNF BETA GENE; TNFSF1 GENE; TNFSF2 GENE; TNFSF3 GENE; GENETIC POLYMORPHISM; GENETICS;

AMINOPEPTIDASES; GENES, MHC CLASS I; GENETIC PREDISPOSITION TO DISEASE; HLA-B27 ANTIGEN; HUMANS; MAJOR HISTOCOMPATIBILITY COMPLEX; POLYMORPHISM, GENETIC; RECEPTORS, KIR; SPONDYLARTHRITIS;

EID: 84938081996     PISSN: 15233774     EISSN: 15346307     Source Type: Journal    
DOI: 10.1007/s11926-015-0516-1     Document Type: Article

References (82)

1. Amor B, Feldmann JL, Delbarre F, Hors J, Beaujan MM, Dausset J. Letter: HL-A antigen W27–a genetic link between ankylosing spondylitis and Reiter’s syndrome? N Engl J Med. 1974;290(10):572.
2. Rudwaleit M, van der Heijde D, Landewe R, Akkoc N, Brandt J, Chou CT, et al. The assessment of SpondyloArthritis International Society classification criteria for peripheral spondyloarthritis and for spondyloarthritis in general. Ann Rheum Dis. 2010;70(1):25–31.
3. Costantino F, Talpin A, Said-Nahal R, Goldberg M, Henny J, Chiocchia G, et al. Prevalence of spondyloarthritis in reference to HLA-B27 in the French population: results of the GAZEL cohort. Ann Rheum Dis. 2015;74(4):689–93. Important epidemiological study combining for the first time HLA-B27 typing to SpA prevalence, using the new ASAS classification criteria.
4. Strand V, Rao SA, Shillington AC, Cifaldi MA, Mcguire M, Ruderman EM. Prevalence of axial spondyloarthritis in United States rheumatology practices: assessment of SpondyloArthritis International Society criteria versus rheumatology expert clinical diagnosis: ASAS criteria versus clinical diagnosis in axial SpA. Arthritis Care Res. 2013;65(8):1299–306.
5. Breban M, Said-Nahal R, Hugot J-P, Miceli-Richard C. Familial and genetic aspects of spondyloarthropathy. Rheum Dis Clin N Am. 2003;29(3):575–94.
6. Said-Nahal R, Miceli-Richard C, Berthelot JM, Duché A, Dernis-Labous E, Le Blévec G, et al. The familial form of spondylarthropathy: a clinical study of 115 multiplex families. Groupe Français d’Etude Génétique des Spondylarthropathies. Arthritis Rheum. 2000;43(6):1356–65.
7. Said-Nahal R, Miceli-Richard C, D’Agostino MA, Dernis-Labous E, Berthelot JM, Duché A, et al. Phenotypic diversity is not determined by independent genetic factors in familial spondylarthropathy. Arthritis Rheum. 2001;45(6):478–84.
8. Baeten D, Breban M, Lories R, Schett G, Sieper J. Are spondylarthritides related but distinct conditions or a single disease with a heterogeneous phenotype? Arthritis Rheum. 2013;65(1):12–20. Up to date review on SpA concept: reality and controversies.
9. Brown MA, Kennedy LG, MacGregor AJ, Darke C, Duncan E, Shatford JL, et al. Susceptibility to ankylosing spondylitis in twins: the role of genes, HLA, and the environment. Arthritis Rheum. 1997;40(10):1823–8.
10. Khan MA. Polymorphism of HLA-B27: 105 subtypes currently known. Curr Rheumatol Rep. 2013;15(10):362.
11. Cortes A, Hadler J, Pointon JP, Robinson PC, Karaderi T, Leo P, et al. Identification of multiple risk variants for ankylosing spondylitis through high-density genotyping of immune-related loci. Nat Genet. 2013;45(7):730–8. The largest case-control genetic study ever performed in ankylosing spondylitis resulted in doubling the number of known associated loci.
12. Breban M, Miceli-Richard C, Zinovieva E, Monnet D, Said-Nahal R. The genetics of spondyloarthropathies. Joint Bone Spine Rev Rhum. 2006;73(4):355–62.
13. Khan MA, Kushner I, Braun WE. Comparison of clinical features in HLA-B27 positive and negative patients with ankylosing spondylitis. Arthritis Rheum. 1977;20(4):909–12.
14. Porcher R, Said-Nahal R, D’Agostino M-A, Miceli-Richard C, Dougados M, Breban M. Two major spondylarthropathy phenotypes are distinguished by pattern analysis in multiplex families. Arthritis Rheum. 2005;53(2):263–71.
15. Brown MA, Laval SH, Brophy S, Calin A. Recurrence risk modelling of the genetic susceptibility to ankylosing spondylitis. Ann Rheum Dis. 2000;59(11):883–6.
16. Dernis E, Said-Nahal R, D’Agostino M-A, Aegerter P, Dougados M, Breban M. Recurrence of spondylarthropathy among first-degree relatives of patients: a systematic cross-sectional study. Ann Rheum Dis. 2009;68(4):502–7.
17. Miceli-Richard C. Significant linkage to spondyloarthropathy on 9q31-34. Hum Mol Genet. 2004;13(15):1641–8.
18. Caffrey MFP, James DCO. Human lymphocyte antigen association in ankylosing spondylitis. Nature. 1973;242(5393):121.
19. Khan MA, Mathieu A, Sorrentino R, Akkoc N. The pathogenetic role of HLA-B27 and its subtypes. Autoimmun Rev. 2007;6(3):183–9.
20. de Castro JA L. HLA-B27 and ankylosing spondylitis: tales from China. Tissue Antigens. 2010;75(1):9–11.
21. Chavan H, Samant R, Deshpande A, Mankeshwar R. Correlation of HLA B27 subtypes with clinical features of ankylosing spondylitis. Int J Rheum Dis. 2011;14(4):369–74.
22. Hill AV, Allsopp CE, Kwiatkowski D, Anstey NM, Greenwood BM, McMichael AJ. HLA class I typing by PCR: HLA-B27 and an African B27 subtype. Lancet. 1991;337(8742):640–2.
23. Kchir MM, Hamdi W, Laadhar L, Kochbati S, Kaffel D, Saadellaoui K, et al. HLA-B, DR and DQ antigens polymorphism in Tunisian patients with ankylosing spondylitis (a case–control study). Rheumatol Int. 2010;30(7):933–9.
24. Liu X, Hu L-H, Li Y-R, Chen F-H, Ning Y, Yao Q-F. The association of HLA-B*27 subtypes with ankylosing spondylitis in Wuhan population of China. Rheumatol Int. 2010;30(5):587–90.
25. Armas JB, Gonzalez S, Martinez-Borra J, Laranjeira F, Ribeiro E, Correia J, et al. Susceptibility to ankylosing spondylitis is independent of the Bw4 and Bw6 epitopes of HLA-B27 alleles. Tissue Antigens. 1999;53(3):237–43.
26. Díaz-Peña R, López-Vázquez A, López-Larrea C. Old and new HLA associations with ankylosing spondylitis: HLA associations with ankylosing spondylitis. Tissue Antigens. 2012;80(3):205–13.
27. Van Gaalen FA. Does HLA-B*2706 protect against ankylosing spondylitis? A meta-analysis: metanalysis of HLA-B*2706 in ankylosing spondylitis. Int J Rheum Dis. 2012;15(1):8–12.
28. Paladini F, Taccari E, Fiorillo MT, Cauli A, Passiu G, Mathieu A, et al. Distribution of HLA-B27 subtypes in Sardinia and continental Italy and their association with spondylarthropathies. Arthritis Rheum. 2005;52(10):3319–21.
29. Siala M, Mahfoudh N, Gdoura R, Younes M, Fourati H, Kammoun A, et al. Distribution of HLA-B27 and its alleles in patients with reactive arthritis and with ankylosing spondylitis in Tunisia. Rheumatol Int. 2009;29(10):1193–6.
30. Ben Radhia K, Ayed-Jendoubi S, Sfar I, Ben Romdhane T, Makhlouf M, Gorgi Y, et al. Distribution of HLA-B*27 subtypes in Tunisians and their association with ankylosing spondylitis. Joint Bone Spine Rev Rhum. 2008;75(2):172–5.
31. Taurog JD. The mystery of HLA-B27: if it isn’t one thing, it’s another. Arthritis Rheum. 2007;56(8):2478–81.
32. Fiorillo MT, Cauli A, Carcassi C, Bitti PP, Vacca A, Passiu G, et al. Two distinctive HLA haplotypes harbor the B27 alleles negatively or positively associated with ankylosing spondylitis in Sardinia: implications for disease pathogenesis. Arthritis Rheum. 2003;48(5):1385–9.
33. Diyarbakir E, Eyerci N, Melikoglu M, Topcu A, Pirim I. HLA B27 subtype distribution among patients with ankylosing spondylitis in Eastern Turkey. Genet Test Mol Biomark. 2012;16(5):456–8.
34. Park S-H, Kim J, Kim S-G, Kim S-K, Chung WT, Choe J-Y. Human leucocyte antigen-B27 subtypes in Korean patients with ankylosing spondylitis: higher B*2705 in the patient group. Int J Rheum Dis. 2009;12(1):34–8.
35. Benjamin R, Parham P. Guilt by association: HLA-B27 and ankylosing spondylitis. Immunol Today. 1990;11(4):137–42.
36. Infantes S, Lorente E, Barnea E, Beer I, Barriga A, Lasala F, et al. Natural HLA-B*2705 protein ligands with glutamine as anchor motif: implications for HLA-B27 association with spondylarthropathy. J Biol Chem. 2013;288(15):10882–9.
37. Schittenhelm RB, Sian TCCLK, Wilmann PG, Dudek NL, Purcell AW. Revisiting the arthritogenic peptide theory: quantitative not qualitative changes in the peptide repertoire of HLA-B27 allotypes. Arthritis Rheum Hoboken NJ. 2015;67(3):702–13.
38. Marcilla M. López de Castro JA. Peptides: the cornerstone of HLA-B27 biology and pathogenetic role in spondyloarthritis. Tissue Antigens. 2008;71(6):495–506.
39. Breban M, Fernández-Sueiro JL, Richardson JA, Hadavand RR, Maika SD, Hammer RE, et al. T cells, but not thymic exposure to HLA-B27, are required for the inflammatory disease of HLA-B27 transgenic rats. J Immunol Baltim Md 1950. 1996;156(2):794–803.
40. May E, Dorris ML, Satumtira N, Iqbal I, Rehman MI, Lightfoot E, et al. CD8 alpha beta T cells are not essential to the pathogenesis of arthritis or colitis in HLA-B27 transgenic rats. J Immunol Baltim Md 1950. 2003;170(2):1099–105.
41. Taurog JD, Dorris ML, Satumtira N, Tran TM, Sharma R, Dressel R, et al. Spondylarthritis in HLA-B27/human beta2-microglobulin-transgenic rats is not prevented by lack of CD8. Arthritis Rheum. 2009;60(7):1977–84.
42. Van Gaalen FA, Verduijn W, Roelen DL, Bohringer S, Huizinga TWJ, van der Heijde DM, et al. Epistasis between two HLA antigens defines a subset of individuals at a very high risk for ankylosing spondylitis. Ann Rheum Dis. 2013;72(6):974–8. Important study of the epistatic interaction between HLA-B27 and HLA-B60 (HLA-B*40:01) with regard to SpA predisposition.
43. Robinson WP, van der Linden SM, Khan MA, Rentsch HU, Cats A, Russell A, et al. HLA-Bw60 increases susceptibility to ankylosing spondylitis in HLA-B27+ patients. Arthritis Rheum. 1989;32(9):1135–41.
44. Wei JCC, Tsai WC, Lin HS, Tsai CY, Chou CT. HLA-B60 and B61 are strongly associated with ankylosing spondylitis in HLA-B27-negative Taiwan Chinese patients. Rheum Oxf Engl. 2004;43(7):839–42.
45. Díaz-Peña R, Ouédraogo DD, López-Vázquez A, Sawadogo SA, López-Larrea C. Ankylosing spondylitis in three sub-Saharan populations: HLA-B*27 and HLA-B*14 contribution. Tissue Antigens. 2012;80(1):14–5.
46. Merino E, Galocha B, Vázquez MN. López De Castro JA. Disparate folding and stability of the ankylosing spondylitis-associated HLA-B*1403 and B*2705 proteins. Arthritis Rheum. 2008;58(12):3693–704.
47. Martinez-Borra J, Gonzalez S, López-Vazquez A, Gelaz M, Armas JB, Kanga U, et al. HLA-B27 alone rather than B27-related class I haplotypes contributes to ankylosing spondylitis susceptibility. Hum Immunol. 2000;61(2):131–9.
48. Zhou X, Wang J, Zou H, Ward MM, Weisman MH, Espitia MG, et al. MICA, a gene contributing strong susceptibility to ankylosing spondylitis. Ann Rheum Dis. 2014;73(8):1552–7. Important genetic study showing an association between several MICA alleles and ankylosing spondylitis in two distinct populations.
49. Groh V, Wu J, Yee C, Spies T. Tumour-derived soluble MIC ligands impair expression of NKG2D and T-cell activation. Nature. 2002;419(6908):734–8.
50. Cascino I, Paladini F, Belfiore F, Cauli A, Angelini C, Fiorillo MT, et al. Identification of previously unrecognized predisposing factors for ankylosing spondylitis from analysis of HLA–B27 extended haplotypes in Sardinia. Arthritis Rheum. 2007;56(8):2640–51.
51. Paladini F, Belfiore F, Cocco E, Carcassi C, Cauli A, Vacca A, et al. HLA-E gene polymorphism associates with ankylosing spondylitis in Sardinia. Arthritis Res Ther. 2009;11(6):R171.
52. Said-Nahal R, Miceli-Richard C, Gautreau C, Tamouza R, Borot N, Porcher R, et al. The role of HLA genes in familial spondyloarthropathy: a comprehensive study of 70 multiplex families. Ann Rheum Dis. 2002;61(3):201–6.
53. Hwang M, Zhou X, Weisman MH, Ward MM, Wang J, Gensler LS, et al. Shared HLA class I and II alleles in susceptibility to ankylosing spondylitis among three ethnic groups. Arthritis Rheum. 2014;66(10, SI):S271.
54. Díaz-Peña R, Aransay AM, Bruges-Armas J, López-Vázquez A, Rodríguez-Ezpeleta N, Mendibil I, et al. Fine mapping of a major histocompatibility complex in ankylosing spondylitis: association of the HLA-DPA1 and HLA-DPB1 regions. Arthritis Rheum. 2011;63(11):3305–12.
55. Díaz-Peña R, Castro-Santos P, Aransay AM, Brüges-Armas J, Pimentel-Santos FM, López-Larrea C. Genetic study confirms association of HLA-DPA1(∗)01:03 subtype with ankylosing spondylitis in HLA-B27-positive populations. Hum Immunol. 2013;74(6):764–7. Important confirmatory study replicating an association of HLA-DPA gene with ankylosing spondylitis in Hispanic populations.
56. Wellcome Trust Case Control Consortium, Australo-Anglo-American Spondylitis Consortium (TASC), Burton PR, Clayton DG, Cardon LR, Craddock N, et al. Association scan of 14,500 nonsynonymous SNPs in four diseases identifies autoimmunity variants. Nat Genet. 2007;39(11):1329–37.
57. Reveille JD, Sims A-M, Danoy P, Evans DM, Leo P, Pointon JJ, et al. Genome-wide association study of ankylosing spondylitis identifies non-MHC susceptibility loci. Nat Genet. 2010;42(2):123–7.
58. Evans DM, Spencer CCA, Pointon JJ, Su Z, Harvey D, Kochan G, et al. Interaction between ERAP1 and HLA-B27 in ankylosing spondylitis implicates peptide handling in the mechanism for HLA-B27 in disease susceptibility. Nat Genet. 2011;43(8):761–7.
59. Kadi A, Izac B, Said-Nahal R, Leboime A, Van Praet L, de Vlam K, et al. Investigating the genetic association between ERAP1 and spondyloarthritis. Ann Rheum Dis. 2013;72(4):608–13.
60. Alvarez-Navarro C, de Castro JA L. ERAP1 structure, function and pathogenetic role in ankylosing spondylitis and other MHC-associated diseases. Mol Immunol. 2014;57(1):12–21.
61. Costantino F, Talpin A, Evnouchidou I, Kadi A, Leboime A, Said-Nahal R, et al. ERAP1 gene expression is influenced by non-synonymous polymorphisms associated with predisposition to spondyloarthritis. Arthritis Rheum Hoboken NJ. 2015. doi:10.1002/art.39072.
62. Carter KW, Pluzhnikov A, Timms AE, Miceli-Richard C, Bourgain C, Wordsworth BP, et al. Combined analysis of three whole genome linkage scans for ankylosing spondylitis. Rheumatology. 2007;46(5):763–71.
63. Falco M, Moretta L, Moretta A, Bottino C. KIR and KIR ligand polymorphism: a new area for clinical applications? Tissue Antigens. 2013;82(6):363–73.
64. Díaz-Peña R, Vidal-Castiñeira JR, Mulero J, Sánchez A, Queiro R, López-Larrea C. Activating killer immunoglobulin-like receptors genes are associated with increased susceptibility to ankylosing spondylitis: KIR locus polymorphism in ankylosing spondylitis. Clin Exp Immunol. 2014. doi:10.1111/cei.12568.
65. García-Medel N, Sanz-Bravo A, Alvarez-Navarro C, Gómez-Molina P, Barnea E, Marcilla M, et al. Peptide handling by HLA-B27 subtypes influences their biological behavior, association with ankylosing spondylitis and susceptibility to endoplasmic reticulum aminopeptidase 1 (ERAP1). Mol Cell Proteomics MCP. 2014;13(12):3367–80.
66. Seregin SS, Rastall DPW, Evnouchidou I, Aylsworth CF, Quiroga D, Kamal RP, et al. Endoplasmic reticulum aminopeptidase-1 alleles associated with increased risk of ankylosing spondylitis reduce HLA-B27 mediated presentation of multiple antigens. Autoimmunity. 2013;46(8):497–508.
67. McHugh K, Bowness P. The link between HLA-B27 and SpA—new ideas on an old problem. Rheumatology. 2012;51(9):1529–39.
68. Payeli SK, Kollnberger S, Marroquin Belaunzaran O, Thiel M, McHugh K, Giles J, et al. Inhibiting HLA-B27 homodimer-driven immune cell inflammation in spondylarthritis. Arthritis Rheum. 2012;64(10):3139–49.
69. Colbert RA, Tran TM, Layh-Schmitt G. HLA-B27 misfolding and ankylosing spondylitis. Mol Immunol. 2014;57(1):44–51.
70. Neerinckx B, Carter S, Lories RJ. No evidence for a critical role of the unfolded protein response in synovium and blood of patients with ankylosing spondylitis. Ann Rheum Dis. 2014;73(3):629–30.
71. Ciccia F, Accardo-Palumbo A, Rizzo A, Guggino G, Raimondo S, Giardina A, et al. Evidence that autophagy, but not the unfolded protein response, regulates the expression of IL-23 in the gut of patients with ankylosing spondylitis and subclinical gut inflammation. Ann Rheum Dis. 2014;73(8):1566–74.
72. Utriainen L, Firmin D, Wright P, Cerovic V, Breban M, McInnes I, et al. Expression of HLA-B27 causes loss of migratory dendritic cells in a rat model of spondylarthritis. Arthritis Rheum. 2012;64(10):3199–209.
73. Dhaenens M, Fert I, Glatigny S, Haerinck S, Poulain C, Donnadieu E, et al. Dendritic cells from spondylarthritis-prone HLA-B27-transgenic rats display altered cytoskeletal dynamics, class II major histocompatibility complex expression, and viability. Arthritis Rheum. 2009;60(9):2622–32.
74. Hacquard-Bouder C, Falgarone G, Bosquet A, Smaoui F, Monnet D, Ittah M, et al. Defective costimulatory function is a striking feature of antigen-presenting cells in an HLA-B27-transgenic rat model of spondylarthropathy. Arthritis Rheum. 2004;50(5):1624–35.
75. Hacquard-Bouder C, Chimenti M-S, Giquel B, Donnadieu E, Fert I, Schmitt A, et al. Alteration of antigen-independent immunologic synapse formation between dendritic cells from HLA-B27-transgenic rats and CD4+ T cells: selective impairment of costimulatory molecule engagement by mature HLA-B27. Arthritis Rheum. 2007;56(5):1478–89.
76. Fert I, Glatigny S, Poulain C, Satumtira N, Dorris ML, Taurog JD, et al. Correlation between dendritic cell functional defect and spondylarthritis phenotypes in HLA-B27/HUMAN beta2-microglobulin-transgenic rat lines. Arthritis Rheum. 2008;58(11):3425–9.
77. Talpin A, Costantino F, Bonilla N, Leboime A, Letourneur F, Jacques S, et al. Monocyte-derived dendritic cells from HLA-B27+ axial spondyloarthritis (SpA) patients display altered functional capacity and deregulated gene expression. Arthritis Res Ther. 2014;16(4):417.
78. Fert I, Cagnard N, Glatigny S, Letourneur F, Jacques S, Smith JA, et al. Reverse interferon signature is characteristic of antigen-presenting cells in human and rat spondyloarthritis. Arthritis Rheum Hoboken NJ. 2014;66(4):841–51. Interesting study showing that both HLA-B27 transgenic rat and SpA patient antigen-presenting cells share a striking « reverse » interferon signature.
79. Glatigny S, Fert I, Blaton MA, Lories RJ, Araujo LM, Chiocchia G, et al. Proinflammatory Th17 cells are expanded and induced by dendritic cells in spondylarthritis-prone HLA-B27-transgenic rats. Arthritis Rheum. 2012;64(1):110–20. This study shows that expression of HLA-B27 in transgenic rat dendritic cells results in a biased activation of CD4+ T cells towards pro-inflammatory Th17 effector profile.
80. Araujo LM, Fert I, Jouhault Q, Labroquère K, Andrieu M, Chiocchia G, et al. Increased production of interleukin-17 over interleukin-10 by Treg cells implicates inducible costimulator molecule in experimental spondyloarthritis: imbalanced production of IL-10 and IL-17 by Treg cells from HLA-B27-transgenic rats. Arthritis Rheum. 2014;66(9):2412–22.
81. Jeanty C, Sourisce A, Noteuil A, Jah N, Wielgosik A, Fert I, et al. HLA-B27 subtype oligomerization and intracellular accumulation patterns correlate with predisposition to spondyloarthritis. Arthritis Rheum Hoboken NJ. 2014;66(8):2113–23. This study reports the intriguing observation that the intra-cellular behavior of SpA-associated HLA-B27 diverges from that of non-associated alleles by more persistent dimers and an accumulation in large saccules.
82. Ruuska M, Sahlberg AS, Colbert RA, Granfors K, Penttinen MA. Enhanced phosphorylation of STAT-1 is dependent on double-stranded RNA-dependent protein kinase signaling in HLA-B27-expressing U937 monocytic cells. Arthritis Rheum. 2012;64(3):772–7.